Literature DB >> 29280433

CD45RO+ T Cells and T Cell Activation in the Long-Lasting Immunity after Leishmania infantum Infection.

João F Rodrigues-Neto1,2, Gloria R Monteiro1, Tatjana S L Keesen2, Henio G Lacerda3,1, Edgar M Carvalho4,5, Selma M B Jeronimo5,1,2.   

Abstract

Manifestations of Leishmania infantum infection range from asymptomatic to symptomatic visceral leishmaniasis (VL). People with symptomatic VL (sVL) have suppressed immune responses against Leishmania antigens that are reversed after clinical cure. The intradermal leishmanin skin test (LST) is negative during sVL, but it becomes positive after treatment. The aim of this study was to compare T cell responses in individuals with sVL, recovered VL (RecVL), and endemic controls. Endemic controls were household contacts of a VL case and they were grouped by their LST results, either positive (LST+) or negative (LST-). Mononuclear cells were studied ex vivo or after stimulation with soluble Leishmania antigens (SLA); cell surface markers and cytokines were determined. T cells, ex vivo, from individuals with sVL and from LST+ individuals presented a higher activation for CD4+ and CD8+ cells expressing CD69. However, lymphocytes from sVL stimulated with SLA had lower percentages of CD4+ and CD8+ cells expressing CD69 and CD8+ cells expressing CD25, with no release of interferon-γ or tumor necrosis factor. sVL subjects had lower percentage of memory cells (CD4+ CD45RO+), ex vivo, without SLA stimulation than RecVL, LST+, or LST- (P = 0.0022). However, individuals with sVL had fewer regulatory cells after SLA stimulation (CD4+ CD25HIGH, P = 0.04 and CD4+ FOXP3+, P = 0.02) than RecVL. The decrease in specific memory and activated CD4+ and CD8+ cells, as in response to Leishmania antigens, could explain, in part, the immune impairment during sVL. Finally, protective T cell responses are long lasting because both RecVL or LST+ individuals maintain a specific protective response to Leishmania years after the primary infection.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29280433      PMCID: PMC5930877          DOI: 10.4269/ajtmh.16-0747

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  57 in total

Review 1.  How Cytokine networks fuel inflammation: Interleukin-17 and a tale of two autoimmune diseases.

Authors:  Dominique L P Baeten; Vijay K Kuchroo
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

Review 2.  Immunologic memory in cutaneous leishmaniasis.

Authors:  Phillip Scott
Journal:  Cell Microbiol       Date:  2005-12       Impact factor: 3.715

3.  Human visceral leishmaniasis is not associated with expansion or accumulation of Foxp3+ CD4 cells in blood or spleen.

Authors:  R Maurya; R Kumar; V K Prajapati; K D Manandhar; D Sacks; S Sundar; S Nylén
Journal:  Parasite Immunol       Date:  2010-07       Impact factor: 2.280

Review 4.  Leishmaniasis: complexity at the host-pathogen interface.

Authors:  Paul Kaye; Phillip Scott
Journal:  Nat Rev Microbiol       Date:  2011-07-11       Impact factor: 60.633

5.  Activated CD4+ CD25+ T cells suppress antigen-specific CD4+ and CD8+ T cells but induce a suppressive phenotype only in CD4+ T cells.

Authors:  Detlef Dieckmann; Heidi Plöttner; Stefanie Dotterweich; Gerold Schuler
Journal:  Immunology       Date:  2005-07       Impact factor: 7.397

6.  Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection.

Authors:  E M Carvalho; R S Teixeira; W D Johnson
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

7.  Epidemiology of visceral leishmaniasis in northeast Brazil.

Authors:  T G Evans; M J Teixeira; I T McAuliffe; I Vasconcelos; A W Vasconcelos; A de A Sousa; J W Lima; R D Pearson
Journal:  J Infect Dis       Date:  1992-11       Impact factor: 5.226

Review 8.  Regulation of CD8+ T cell responses to infection with parasitic protozoa.

Authors:  Kimberly A Jordan; Christopher A Hunter
Journal:  Exp Parasitol       Date:  2010-05-21       Impact factor: 2.011

9.  Role of CD8(+) T cells in protection against Leishmania donovani infection in healed Visceral Leishmaniasis individuals.

Authors:  Himanshu Kaushal; Rachel Bras-Gonçalves; Narender Singh Negi; Jean-Loup Lemesre; Gérard Papierok; Poonam Salotra
Journal:  BMC Infect Dis       Date:  2014-12-03       Impact factor: 3.090

10.  A role for IgG immune complexes during infection with the intracellular pathogen Leishmania.

Authors:  Suzanne A Miles; Sean M Conrad; Renata G Alves; Selma M B Jeronimo; David M Mosser
Journal:  J Exp Med       Date:  2005-03-07       Impact factor: 14.307

View more
  2 in total

1.  Multifunctional, TNF-α and IFN-γ-Secreting CD4 and CD8 T Cells and CD8High T Cells Are Associated With the Cure of Human Visceral Leishmaniasis.

Authors:  Lorranny Santana Rodrigues; Aline Silva Barreto; Lays Gisele Santos Bomfim; Marcos Couto Gomes; Nathalia Luisa Carlos Ferreira; Geydson Silveira da Cruz; Lucas Sousa Magalhães; Amélia Ribeiro de Jesus; Clarisa B Palatnik-de-Sousa; Cristiane Bani Corrêa; Roque Pacheco de Almeida
Journal:  Front Immunol       Date:  2021-10-28       Impact factor: 7.561

Review 2.  A review of the leishmanin skin test: A neglected test for a neglected disease.

Authors:  Jessica Carstens-Kass; Kayla Paulini; Patrick Lypaczewski; Greg Matlashewski
Journal:  PLoS Negl Trop Dis       Date:  2021-07-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.